Navigation Links
GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
Date:11/26/2007

se the synthesis of cholesterol and possibly other products of the cholesterol biosynthesis pathway, MEVACOR is contraindicated during pregnancy and in nursing mothers. MEVACOR should be administered to women of childbearing age only when such patients are highly unlikely to conceive. If the patient becomes pregnant while taking this drug, MEVACOR should be discontinued immediately and the patient should be apprised of the potential hazard to the fetus (see PRECAUTIONS, Pregnancy).

WARNINGS

Myopathy/Rhabdomyolysis

Lovastatin, like other inhibitors of HMG-CoA reductase, occasionally causes myopathy manifested as muscle pain, tenderness or weakness with creatine kinase (CK) above ten times the upper limit of normal (ULN). Myopathy sometimes takes the form of rhabdomyolysis with or without acute renal failure secondary to myoglobinuria, and rare fatalities have occurred. The risk of myopathy is increased by high levels of HMG-CoA reductase inhibitory activity in plasma.

As with other HMG-CoA reductase inhibitors, the risk of myopathy/rhabdomyolysis is dose related. In a clinical study (EXCEL) in which patients were carefully monitored and some interacting drugs were excluded, there was one case of myopathy among 4933 patients randomized to lovastatin 20-40 mg daily for 48 weeks, and 4 among 1649 patients randomized to 80 mg daily.

All patients starting therapy with lovastatin, or whose dose of lovastatin is being increased, should be advised of the risk of myopathy and told to report promptly any unexplained muscle pain, tenderness or weakness. Lovastatin therapy should be discontinued immediately if myopathy is diagnosed or suspected. In most cases, muscle symptoms and CK increases resolved when treatment was promptly discontinued. Periodic CK determinations may be considered in patients starting therapy with lovastatin or whose dose is being increased, but there is no assurance that such monitoring will prevent myopathy.

Many
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
9. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Pearson VUE Signs Exclusive Contract with Educational Resources, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... October 22, 2014 Healthcare professionals ... their continuing education at home or on-the-go via ... to 20 brand new, premium Seminar-on-Demand CE courses. ... of over 2,000 hours of CE ... their educational experience. With such a diverse library, ...
(Date:10/22/2014)... WALTHAM, MA (PRWEB) October 22, 2014 ... developing new solutions for the treatment of bacterial infections, ... J. Sinskey has joined its board of directors. ... Microbiology and Engineering Systems at The Massachusetts Institute of ... the MIT faculty since 1968. Dr. Sinskey also holds ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, 2014 ... fertilization (IVF) -- the incubation of embryos in a laboratory ... the vagina, new research suggests. Scientists from the United ... might sharply cut costs for pricey IVF procedures among certain ... those who don,t live near big-city assisted reproduction centers, the ...
(Date:10/20/2014)... 20, 2014 With a mere 19 ... Crist made a brief fundraising stop at the ... , Fresh from a debate last night with his ... stage for the first seven minutes because Crist had ... described the incident in one word: "weird." , Before ...
(Date:10/20/2014)... T.E.N., a technology and information security ... William H. Murray, renowned author and industry visionary, ... Award winner. Presented annually, the ISE® Luminary Leadership ... and industry practitioner for his or her distinguished ... security industry. , Formerly with IBM, Murray is ...
Breaking Medicine News(10 mins):Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4
... and predict life-saving developments could follow , WEDNESDAY, June 10 ... cause of a deadly type of ovarian cancer, a finding ... cell tumors. , The culprit is a single mutation out ... code of the tumor. The mutation is present in every ...
... a drug approved in the U.S. for nausea, vomiting and ... a large cohort study published in the June 11 issue ... "The Safety of Metoclopramide Use in the First Trimester of ... 2009). According to the pediatrician and clinical pharmacologist, principal ...
... Studies show that older adults are healthier and happier ... in particular can be a wonderful vehicle for uniting generations. ... Matters: Civic Engagement Symposium," will be held at ... (TODCO)-Coleman House on June 15, 8:30 ...
... and enhanced services delivered through local radiologists , ... ( imaging-advantage.com ), a nationally-recognized radiology management ... at Mercy Health Partners (MHP),s four Metro hospitals: ... and St. Vincent Mercy Children,s Hospital. , ...
... researchers find , WEDNESDAY, June 10 (HealthDay News) -- Though ... apnea, many non-obese people also have the condition, according to ... adults (with a body-mass index between 18.5 and 27), obstructive ... of those with the condition had mild cases and half ...
... or bone marrow transplant, researchers at Children,s Hospital Boston ... marrow as people age, inhibit the marrow,s ability to ... 10 by the journal Nature , suggests that ... after transplant. Patients who have had radiation or ...
Cached Medicine News:Health News:Ovarian Cancer Breakthrough Heralds New Era of Treatment 2Health News:Off-label morning sickness drug deemed safe for fetuses -- Ben-Gurion U. researchers 2Health News:San Francisco Symposium Provides Training for Communities Looking to Develop Arts Programs That Unite Generations 2Health News:San Francisco Symposium Provides Training for Communities Looking to Develop Arts Programs That Unite Generations 3Health News:Imaging Advantage Launches Operations at Mercy Health Partners' Metro Hospitals 2Health News:Trimming the fat boosts blood recovery after marrow transplant 2
(Date:10/22/2014)... Calif. , Oct. 22, 2014  Cephasonics, a ... the introduction of the cQUB™-1 (cQuest Ultrasound Box™-1), the ... ultrasound systems designed and manufactured by Cephasonics for purchase ... and model number. Cephasonics will be showcasing the cQUB-1 ... held this week in Chongqing, China ...
(Date:10/22/2014)... 22, 2014 Antigen Discovery Inc. (ADi), a ... , announced the receipt of a National Institutes of ... from the National Institute of Dental and Craniofacial Research (NIDCR). ... a Pan-HIV Protein Microarray Chip, which will contain every ... and aid in the development of safe and effective ...
(Date:10/22/2014)... Oct. 22, 2014  Paper Pak Industries, a ... APLS ® Body Guard Bio, a disposable, ... of bacteria and virus while protecting service providers ... Bio features a rugged, external nylon shell, watertight ... a leak-proof inner chamber that contains contaminated and ...
Breaking Medicine Technology:Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 3Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2
... Generex Biotechnology Corporation ( www.generex.com ) (OTC: GNBT) today ... DATE: May 5th, 2011 TIME:  11:00 ... watch event now" button. This will be ... to ask the company questions in real-time both in ...
... 2, 2011 Anticipating record attendance among the investment community ... place May 10-11 at the Marriott Resort in Ypsilanti, Mich., ... will vie for funding at this year,s event. The 41 ... businesses and were selected from a competitive pool of 85 ...
Cached Medicine Technology:Generex Biotechnology Corporation CEO to Present Live, Online at RetailInvestorConferences.com on May 5th 2Generex Biotechnology Corporation CEO to Present Live, Online at RetailInvestorConferences.com on May 5th 3Michigan Growth Capital Symposium Unveils Robust Line Up of Presenting Companies for 30th Anniversary Event 2Michigan Growth Capital Symposium Unveils Robust Line Up of Presenting Companies for 30th Anniversary Event 3
...
... is a semi-rigid system intended for ... Slim-LOC is based on the comprehensive, ... market technology. The Slim-LOC system offers ... Reduced width (16 mm), low profile ...
... intended for supportive stabilization of the ... The device utilizes bi-cortical fixation for ... enhanced through dynamic screw holes and ... level interbody fusion. Anterior cervical corpectomy. ...
The Codman anterior cervical plate is designed for immediate internal fixation of the cervical spine following bone grafting procedures....
Medicine Products: